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1. Introduction 
DNA polymerase (i.e., DNA-dependent DNA polymerase [pol], E.C. 2.7.7.7) catalyzes the 
polymerization of deoxyribonucleotides alongside a DNA strand, which it "reads" and uses 
as a template (Kornberg & Baker, 1992). The newly polymerized molecule is complementary 
to the template strand and identical to the template’s partner strand. Pol can add free 
nucleotides only to the 3’ end of the newly formed strand, meaning that elongation of the 
new strand occurs in a 5’ to 3’ direction.  
The human genome encodes at least 14 pols that conduct cellular DNA synthesis (Bebenek 
& Kunkel, 2004; Hubscher et al., 2002). Eukaryotic cells contain 3 DNA replicative pols (α, δ 
and ε), 1 mitochondrial pol (γ), and at least 10 DNA repair and/or recombination-related 
pols (β, ζ, η, θ, ι, κ, λ, µ and ν, and REV1) (Friedberg et al., 2000; Takata et al., 2006). Pols 
have a highly conserved structure, which means that their overall catalytic subunits show 
little variance among species. Enzymes with conserved structures usually perform 
important cellular functions, the maintenance of which provides evolutionary advantages. 
On the basis of sequence homology, eukaryotic pols can be divided into 4 main families, 
termed A, B, X and Y (Friedberg et al., 2000). Family A includes mitochondrial pol γ, as well 
as pols θ and ν. Family B includes 3 DNA replicative pols (α, δ and ε) and pol ζ. Family X 
comprises pols β, λ and µ; and lastly, family Y includes pols η, ι and κ, in addition to REV1.  
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We have been screening for selective inhibitors of each pol derived from natural products 
including food materials and nutrients for more than 15 years (Mizushina, 2009; Sakaguchi 
et al., 2002). In our studies of pol inhibitors, we have found that selective inhibitors of pol λ, 
which is a DNA repair-related pol, have anti-inflammatory activity against 12-O-
tetradecanoylphorbol-13-acetate (TPA)-induced inflammation (Mizushina et al., 2003; 
Mizushina, 2009). Although tumor promoters such as TPA are classified as compounds that 
promote tumor formation (Hecker, 1978), they also cause inflammation and are commonly 
used as artificial inducers of inflammation in order to screen for anti-inflammatory agents 
(Fujiki & Sugimura, 1987). Tumor promoter-induced inflammation can be distinguished 
from acute inflammation, which is exudative and accompanied by fibroblast proliferation 
and granulation. The tumor promoter TPA is frequently used to search for new types of 
anti-inflammatory compound. TPA not only causes inflammation, but also influences 
mammalian cell growth (Nakamura et al., 1995), suggesting that the molecular basis of the 
inflammation stems from pol reactions related to cell proliferation. This relationship, 
however, needs to be investigated more closely.  
In this review, we examine the relationship between pol λ inhibition and anti-inflammation 
using pol λ-specific inhibitors, such as chemically synthesized curcumin derivatives. On the 
basis of these results, the pol λ-inhibitory mechanism and anti-inflammation effects of 
monoacetyl-curcumin, which was the strongest pol λ inhibitor among the compounds 
tested, is discussed.  
2. Effect of curcumin derivatives on the activities of mammalian pols 
2.1 Pol assay for inhibitor screening 
A pol activity assay to detect pol inhibitors was established by Mizushina et al. (1996a; 
1996b; 1997). Purified mammalian pols α, β, γ, δ, ε, η, ι, κ and λ, which have high activity, 
were kind gifts from pol researchers around the world. As shown in Fig. 1, 
poly(dA)/oligo(dT)18 (A/T = 2/1) and 2'-deoxythymidine 5'-triphosphate (dTTP) were used 
as the DNA template-primer and nucleotide (dNTP, 2'-deoxynucleotide 5'-triphosphate) 
substrate, respectively. The candidate inhibitors, which were low molecular weight organic 
compounds, were dissolved in distilled dimethyl sulfoxide (DMSO) at various 
concentrations and sonicated for 30 s. Aliquots (4 µL) of the sonicated samples were mixed 
with 16 µl of each enzyme (final amount 0.05 units) in 50 mM Tris–HCl (pH 7.5) containing 1 
mM dithiothreitol, 50% glycerol and 0.1 mM EDTA, and pre-incubated at 0 ºC for 10 min. 
These inhibitor–enzyme mixtures (8 µL) were then added to 16 µl of each of the enzyme 
standard reaction mixtures, and incubation was carried out at 37 ºC for 60 min, except for 
Taq pol, which was incubated at 74 ºC for 60 min. Activity without the inhibitor was 
considered 100%, and the remaining activity at each concentration of the inhibitor was 
determined relative to this value. One unit of pol activity was defined as the amount of 
enzyme that catalyzed the incorporation of 1 nmol of dNTP (i.e., dTTP) into synthetic DNA 
template–primers in 60 min at 37 ºC under the normal reaction conditions for each enzyme 
(Mizushina et al., 1996b; 1997).  
2.2 Mammalian pol inhibitory effect of curcumin derivatives 
As described above, we are searching for natural inhibitors specific to each of the 
mammalian pols. A phenolic compound produced from a higher plant, a Japanese vegetable  
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Fig. 1. Pol inhibitor assay scheme 
(Petasites japonicus) collected from Akita prefecture, Japan, was found to inhibit pol λ activity 
selectively (Mizushina et al., 2002). The compound was purified and its chemical structure 
was analyzed, and it was identified as petasiphenol (compound 1 in Fig. 2) (Iriye et al., 
1992). The three-dimensional relationship between pol inhibitors and the pol structure was 
investigated, which suggested that some phenolic compounds might be pol inhibitors. It 
was therefore tested whether commercial or easily obtainable phenolic compounds might 
also be pol λ-specific inhibitors. As a result, curcumin (diferuloylmethane, compound 2 in 
Fig. 2), which is the same type of phenolic compound as petasiphenol, and 13 chemically 
synthesized derivatives of curcumin (compounds 3–15 in Fig. 2) were prepared, and then 
tested for their inhibitory effects on mammalian pols.  
The inhibition of four mammalian pols, namely calf pol α, human pol γ, human pol κ and 
human pol λ, by each compound at 10 µM was investigated. Pols α, γ, κ and λ were used as 
representatives of the B, A, Y and X families of pols, respectively (Bebenek & Kunkel, 2004; 
Hubscher et al., 2002; Takata et al., 2006). As shown in Fig. 3, petasiphenol (1) and curcumin 
(2) inhibited human pol λ activity. The inhibitory effect on pol λ of compounds 4, 5, 13 and 
14 was stronger than that of curcumin (2). Compounds 6 to 11, which do not have any enone 
moieties, did not affect pol λ activity; thus, the enone moiety, which is present in 
petasiphenol, might be important or essential for pol λ inhibition. As mentioned above, 
compounds 4, 5 and 13, which have one or more acetoxy moieties, strongly inhibited the 
activity of pol λ, and compound 13 (monoacetyl-curcumin) was the strongest inhibitor 
among the compounds tested. The one acetoxy moiety at position C4” in monoacetyl-
curcumin (13) might stimulate the inhibitory effect on pol λ. On the other hand, at 10 µM, 
none of the compounds inhibited the activity of calf pol α, human pol γ or human pol κ.  
On the basis of these results, we concentrated on curcumin (2), which is a major food 
component, and monoacetyl-curcumin (13), which was the strongest inhibitor of pol λ 
among the curcumin derivatives tested, in the next part of this study.  
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Fig. 2. Structure of curcumin derivatives. Compound 1: petasiphenol; compound 2: 
curcumin (diferuloylmethane); compound 3: (1E,6E)-1,7-bis(3’,4’-dimethoxyphenyl)-4,4-
dimethyl-1,6-heptadien-3,5-dione; compound 4: (1E,4Z,6E)-1,7-bis(4’-acetoxy-3’-
methoxyphenyl)-5-hydroxy-1,4,6-heptatrien-3-one (diacetyl-curcumin); compound 5: 
(1E,6E)-1,7-bis(4’-acetoxy-3’-methoxyphenyl)-4,4-dimethyl-1,6-heptadien-3,5-dione; 
compound 6: 1,7-bis4-hydroxy-3-methoxyphenyl-3,5-heptadione; compound 7: 1,7-bis4-
hydroxy-3-methoxyphenyl-5-hydroxy-3-heptanone; compound 8: 1,7-bis4-hydroxy-3-
methoxyphenyl-3,5-heptadiol; compound 9: 1,7-bis4-acetoxy-3-methoxyphenyl-3,5-
heptadione; compound 10: 1,7-bis4-acetoxy-3-methoxyphenyl-5-hydroxy-3-heptanone; 
compound 11: 1E,6E-1,7-bis4-acetoxy-3-methoxyphenyl-3,5-dihydroxyheptane; compound 
12: 1E,6E-1,7-bis4-hydroxy-3-methoxyphenyl-3,5-dihydroxy-1,6-heptadiene; compound 13: 
(1E,4Z,6E)-7-(4’’-acetoxy-3’’-methoxyphenyl)-5-hydroxy-1-(4’-hydroxy-3’-
methoxyphenyl)hepta-1,4,6-trien-3-one (monoacetyl-curcumin); compound 14: (1E,4Z,6E)-1-
(3’,4’-dimethoxyphenyl)-5-hydroxy-7-[4”-hydroxy-3”-methoxypheny]hepta-1,4,6-trien-3-one 
(monometyl-curcumin); compound 15: 1E,6E-1-3,4-dimethoxyphenyl-4,4-dimethyl-7-4-
methoxyphenylhepta-1,6-dien-3,5-diol. 
3. Effect of curcumin (2) and monoacetyl-curcumin (13) on the activities of 
pols and other DNA metabolic enzymes 
Curcumin (2) and monoacetyl-curcumin (13) were effective at inhibiting human pol λ 
activity, and the inhibition was dose-dependent with 50% inhibition observed at a 
concentration of 7.0 and 3.9 µM, respectively (Table 1). These compounds had no influence 
on the activities of not only DNA replicative pols such as calf pol α, human pol δ and 
human pol ε, or mitochondrial DNA replicative pols such as human pol γ, but also DNA 
repair-related pols such as rat pol β, human pols η, ι and κ. It is interesting that these 
compounds had no affect on the activity of pol β, because pols β and λ both belong to the   
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Fig. 3. Inhibitory effect of curcumin derivatives (compounds 1–15) on the activities of 
mammalian pols. Each compound (10 µM) was incubated with calf pol α (B-family pol), 
human pol γ (A-family pol), human pol κ (Y-family pol) and human pol λ (X-family pol) 
(0.05 units each). Pol activity in the absence of the compound was taken as 100%, and the 
relative activity is shown. Data are shown as the mean ± SE (n=3).  
X-family of pols, and the three-dimensional structure of pol β is thought to be highly similar 
to pol λ (Garcia-Diaz et al., 2004).  
Curcumin (2) and monoacetyl-curcumin (13) also had no inhibitory effect on cherry salmon 
(fish) pols α and δ, cauliflower (higher plant) pol α, prokaryotic pols such as the Klenow 
fragment of E. coli pol I, Taq pol and T4 pol, and other DNA metabolic enzymes such as calf 
DNA primase of pol α, human immunodeficiency virus type-1 (HIV-1) reverse 
transcriptase, T7 RNA polymerase, T4 polynucleotide kinase and bovine deoxyribonuclease 
I. Therefore, these phenolic compounds were specific inhibitors of human pol λ among the 
pols and DNA metabolic enzymes tested. Petasiphenol (1) also selectively inhibited the 
activity of eukaryotic pol λ such as curcumin (2) and monoacetyl-curcumin (13) (Mizushina 
et al., 2002).  
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Enzyme 
IC50 value (µM) 
Curcumin (2) Monoacetyl-curcumin (13) 
– Mammalian DNA polymerases –   
Calf DNA polymerase α >100 >100 
Rat DNA polymerase β >100 >100 
Human DNA polymerase γ >100 >100 
Human DNA polymerase δ >100 >100 
Human DNA polymerase ε >100 >100 
Human DNA polymerase η >100 >100 
Human DNA polymerase ι >100 >100 
Human DNA polymerase κ >100 >100 
Human DNA polymerase λ 7.0 ± 0.39 3.9 ± 0.25 
– Fish DNA polymerases –   
Cherry salmon DNA polymerase α >100 >100 
Cherry salmon DNA polymerase δ >100 >100 
– Plant DNA polymerases –   
Cauliflower DNA polymerase α >100 >100 
– Prokaryotic DNA polymerases –   
E. coli DNA polymerase I >100 >100 
Taq DNA polymerase >100 >100 
T4 DNA polymerase >100 >100 
– Other DNA metabolic enzymes –   
Calf primase of DNA polymerase α >100 >100 
HIV-1 reverse transcriptase >100 >100 
T7 RNA polymerase >100 >100 
T4 polynucleotide kinase >100 >100 
Bovine deoxyribonuclease I >100 >100 
Table 1. IC50 values of curcumin (2) and monoacetyl-curcumin (13) for various pols and 
other DNA metabolic enzymes. The compounds were incubated with each enzyme (0.05 
units). Enzyme activity in the absence of the compound was taken as 100%. Data are shown 
as the mean ± SE (n=3).  
When activated DNA (i.e., bovine deoxyribonuclease I-treated DNA) and dNTP were used 
as the DNA template-primer and nucleotide substrate instead of synthesized DNA 
[poly(dA)/oligo(dT)18 (A/T = 2/1)] and dTTP, respectively, the inhibitory effects of these 
compounds did not change.  
4. Effect of curcumin derivatives on TPA-induced anti-inflammatory activity 
As mentioned in the Introduction, TPA is known to cause inflammation and is commonly 
used in screens for anti-inflammatory agents (Fujiki & Sugimura, 1987). Curcumin (2) is 
known as an anti-TPA-induced inflammatory compound (Ammon & Wahl, 1991), but the 
other agents (compounds 1 and 3–15) had not previously been tested for anti-TPA-induced 
inflammatory activity.  
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Fig. 4. Anti-inflammatory activity of curcumin derivatives (compounds 1–15) toward TPA-
induced edema on mouse ear. Each compound (250 µg) was applied to one of the mouse 
ears and, after 30 min, TPA (0.5 µg) was applied to both ears. Edema was evaluated after 7 h. 
The anti-inflammatory activity (%) is expressed as the percentage reduction in edema as 
compared with the non-treated ear. Data are shown as the mean ± SE (n=5).  
Using an inflammation test in mice, the anti-inflammatory activity of these compounds was 
examined. The application of TPA (0.5 µg) to a mouse ear induced edema with a 241% 
increase in the weight of the ear disk at 7 h after application. As expected, curcumin (2) 
inhibited this inflammation at an applied dose of at least 250 µg (inhibitory effect (IE) = 63%) 
(Fig. 4). Petasiphenol (1), which was purified from Japanese vegetable (Petasites japonicus), 
was also an anti-inflammatory agent, although its effect was a third weaker than that of 
curcumin (2). Thus, both petasiphenol (1) and curcumin (2) could be potent inhibitors of 
inflammation caused by TPA. Interestingly, other curcumin derivatives also caused a 
marked reduction in TPA-induced inflammation: notably, the anti-inflammatory effect of 
monoacetyl-curcumin (13) was stronger than that of curcumin (2) with an IE of 81%, 
indicating that this compound possesses strong anti-inflammatory activity.  
5. Structure–activity relationship of curcumin derivatives 
Pol λ inhibition had a significant correlation (correlation coefficient = 0.9608) with anti-
inflammatory activity, as shown by Fig. 3 and Fig. 4, which led us to speculate that TPA-
induced inflammation may involve a process requiring pol λ, which is a DNA repair-related 
pol. Thus, to confirm whether there is a relationship between pol λ inhibition and anti-
inflammation, the inhibitory effects of the curcumin derivatives (compounds 1–15) on the 
two bio-activities were compared.  
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Among the fifteen curcumin derivatives tested, including curcumin (2) itself (Fig. 1), 
monoacetyl-curcumin (13) was the strongest inhibitor of both pol λ and anti-inflammation. 
Considering the structure of monoacetyl-curcumin (13) (Fig. 5), the essential moieties of the 
structure for these activities might be: <1> two enone moieties, <2> one hydroxyl group at 
position C4’, and <3> one acetoxy group at position C4”. These moieties are specific to 
monoacetyl-curcumin (13); therefore, these moieties are likely to be involved in the activities 
of both pol λ inhibition and anti-inflammation.  
 
< 1 > < 1 >
< 2 > < 3 >
O
HO O
O
O O
Ac
1’3’
4’
1” 3”
4”
 
Fig. 5. Chemical structure of monoacetyl-curcumin (13). The functional groups likely to be 
essential for both pol λ inhibitory activity and anti-inflammatory activity in the curcumin 
derivatives are shown (<1> to <3>).  
6. Inhibitory activity of curcumin (2) and monoacetyl-curcumin (13) against 
inflammatory responses in cultured cells 
Next, because curcumin (2) and monoacetyl-curcumin (13) might be chemical knockout 
agents for DNA repair-related pol λ activity (Table 1), we used these compounds to 
investigate the anti-inflammatory mechanism of pol λ specific inhibitors in the murine 
macrophage cell line RAW264.7 treated with lipopolysaccharide (LPS or endotoxin), which 
stimulates macrophages to release inflammatory cytokines, interleukins (ILs) and tumor 
necrosis factor (TNF) (Hsu & Wen, 2002).  
RAW264.7 cells were seeded on a 12-well plate at 1x105 cells/well and incubated for 24 h. 
The cells were pre-treated with 10 or 50 µM curcumin (2) or monoacetyl-curcumin (13) for 
30 min and then stimulated with 100 ng/mL of LPS. After 30 min or 24 h, the cell culture 
medium was collected to measure the levels of inflammatory cytokines, such as tumor 
necrosis factor-α (TNF-α), nuclear factor-κB (NF-κB) and IκB. In RAW264.7 cells, 
cytotoxicity of these compounds at 50 µM was not observed (data not shown).  
As shown in Fig. 6A, at 50 µM, curcumin (2) and monoacetyl-curcumin (13) both 
significantly suppressed LPS-stimulated production of TNF-α, and monoacetyl-curcumin 
(13) showed greater inhibition than curcumin (2). At 10 µM, monoacetyl-curcumin (13) still 
showed suppression of TNF-α production, although curcumin (2) at 10 µM did not 
significantly inhibit TNF-α production.  
Next, the effect of monoacetyl-curcumin (13) on the expression level of pol λ protein in LPS-
treated RAW264.7 cells was investigated. Fig. 6B shows that these macrophages underwent 
a more than 3-fold increase in the expression of pol λ after LPS stimulation, but this increase 
was suppressed by 50 µM monoacetyl-curcumin (13). These results suggest that there is the 
positive correlation between inflammatory induction by LPS and pol λ expression; thus, not 
only the DNA polymerization activity but also the protein expression of DNA repair-related 
pol λ is likely to be important in inflammation.  
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NF-κB is known to be the rate-controlling factor in inflammatory responses. Therefore, the 
inhibitory effects of curcumin (2) and monoacetyl-curcumin (13) on the LPS-induced nuclear 
translocation of NF-κB were examined in RAW264.7 cells. At 50 µM, curcumin (2) and 
monoacetyl-curcumin (13) both inhibited NF-κB nuclear translocation stimulated by 100 
ng/mL of LPS, and the effect of monoacetyl-curcumin (13) was stronger than that of 
curcumin (2) (Fig. 6C). Stimulation with LPS results in activation of Toll-like receptor 4 and 
the downstream IκB kinases (IKKs), which in turn phosphorylate IκB, leading to 
degradation of IκB and translocation of NF-κB into the nucleus (Hashimoto et al., 2002). 
Therefore, the suppressive effects of curcumin (2) and monoacetyl-curcumin (13) on the 
LPS-induced phosphorylation of IκB were examined in RAW264.7 cells. By Western blot 
analysis, it was revealed that, at 50 µM, both curcumin (2) and monoacetyl-curcumin (13) 
significantly inhibited the LPS-induced phosphorylation of IκB (Fig. 6D). These results 
demonstrate that monoacetyl-curcumin (13), as well as curcumin (2), suppresses NF-κB 
nuclear translocation by inhibiting the phosphorylation of IκB.  
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Fig. 6. Inhibitory activities of curcumin (2) and monoacetyl-curcumin (13) against 
inflammatory responses in the cultured murine macrophage cell line RAW264.7. (a) 
RAW264.7 cells were pre-treated with 10 or 50 µM curcumin (2) or monoacetyl-curcumin 
(13) for 30 min and then incubated with 100 ng/mL of LPS for 24 h. The TNF-α level in the 
culture medium was measured by ELISA. Data are shown as the mean ± SE (n=4). (b) 
RAW264.7 cells were pre-treated with 50 µM monoacetyl-curcumin (13), and then incubated 
with 100 ng/mL of LPS for 30 min. The expression level of pol λ was evaluated by Western 
blot analysis. The intensity of each band was analyzed, and the values relative to non-
treatment with LPS are represented at the lower edge of the image. (c and d) RAW264.7 cells 
were pre-treated with 50 µM curcumin (2) or monoacetyl-curcumin (13), and then incubated 
with 100 ng/mL of LPS for 30 min. Nuclear translocation of NF-κB p65 (c) and the 
phosphorylation of IκB (d) were evaluated by Western blot analysis. The intensity of each 
band was analyzed, and the values relative to treatment with LPS alone are represented at 
the lower edge of the image. (e) RAW264.7 cells were pre-treated with 50 µM curcumin (2) 
or monoacetyl-curcumin (13) for 30 min, and then treated with 50 ng/mL of TNF-α and 4 
µM DCFH-DA for 30 min. The fluorescent intensity of DCF, which indicates ROS 
production, was measured as described in a previous report (Corda et al., 2001). Data are 
shown as the mean ± SE (n=4).  
www.intechopen.com
Inhibition of DNA Polymerase λ, a DNA Repair Enzyme, and Anti-Inflammation:  
Chemical Knockout Analysis for DNA Polymerase λ Using Curcumin Derivatives 
 
787 
Anti-oxidative activity has been reported to be linked to anti-inflammatory activity 
(Rahman et al., 2006). We therefore investigated the anti-oxidative activity of curcumin (2) 
and monoacetyl-curcumin (13) against the production of reactive oxygen species (ROS) 
induced by TNF-α. Measurement of intracellular ROS was performed according to the 
method of a previous report (Corda et al., 2001). In RAW264.7 cells, at 50 µM, the two 
compounds decreased the production of ROS by 50 ng/mL of TNF-α to 59.5% and 32.1%, 
respectively (Fig. 6E). These results suggest that both compounds possess anti-oxidative 
activity, but that monoacetyl-curcumin (13) has stronger activity than curcumin (2).  
7. Inhibitory activity of curcumin (2) and monoacetyl-curcumin (13) against 
LPS-induced inflammation in vivo 
To assess their anti-inflammatory effects in vivo, the inhibitory activity of curcumin (2) and 
monoacetyl-curcumin (13) against LPS-induced acute inflammation was investigated in 
mice (Fig. 7). As shown in Fig. 7A, treatment with 250 µg/kg (body weight, BW) of LPS 
increased the serum TNF-α level, and an oral injection of 100 mg/kg (BW) of monoacetyl-
curcumin (13) significantly decreased the LPS-induced production of TNF-α to 36%. By 
contrast, curcumin (2) had no effect. Next, the inhibitory effects of these compounds on 
nuclear translocation of NF-κB in the liver were examined. Fig. 7B shows that LPS caused 
translocation of NF-κB into the nucleus, and monoacetyl-curcumin (13) blocked this nuclear 
translocation. Notably, curcumin (2) also inhibited nuclear translocation of NF-κB even 
though it did not block TNF-α production.  
The serum levels of curcumin (2) and monoacetyl-curcumin (13) 2 h after oral 
administration were measured in the mice by liquid-chromatography mass spectrometry. 
The serum concentrations were below the detection limit and, thus, were less than 0.3 nM 
for both curcumin (2) and monoacetyl-curcumin (13) (data not shown). It has been reported 
that curcumin (2) is poorly absorbed in the body (Anand et al., 2007). Thus, a lower 
concentration of monoacetyl-curcumin (13) than of curcumin (2) might be able to decrease 
the serum TNF-α level in mice treated with LPS.  
8. Discussion 
Inflammatory mediators, such as TPA and LPS, quickly stimulate ROS (Hsu & Wen, 
2002), and ROS are known to mediate oxidative DNA damage. As shown in Fig. 8, DNA 
repair pols such as pol λ induce protein expression and increase DNA polymerization 
activity to repair the damaged DNA. Furthermore, we consider that pol λ might have a 
great effect on inflammatory responses, such as TNF-α production, NF-κB activation, 
secretion of cytokines [e.g. interferons (IFNs) and interleukins (ILs) etc], tissue damage 
and cell death. The results summarized in this review suggest that inhibition of DNA 
repair by pol λ is related to anti-inflammatory pathways, and that pol λ-specific inhibitors 
such as monoacetyl-curcumin (13) might be chemotherapeutic drugs for inflammatory 
diseases. The detailed molecular mechanism underlying the correlation between DNA 
repair inhibition by pol λ and anti-inflammatory responses is not yet known; therefore, 
experiments with small interfering RNA (siRNA) targeting pol λ would help in further 
analyses.  
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(b) 
Fig. 7. The inhibitory activity of curcumin (2) and monoacetyl-curcumin (13) against LPS-
induced inflammation in vivo. Male 8-week-old C57BL/6 mice were given an oral dose of 
100 mg/kg (BW) of curcumin (2) or monoacetyl-curcumin (13) dissolved in corn oil or 200 
µL of corn oil as a vehicle control. After 2 h, the mice were intraperitoneally injected with 
250 µg/kg (BW) of LPS dissolved in phosphate-buffered saline (PBS) or 200 µL of PBS as a 
vehicle control. After 1 h, the mice were killed. (a) The TNF-α level in serum was measured 
by ELISA. Data are shown as the mean ± SE (n=4). The treatment with corn oil and LPS 
(positive control) was taken as 100% (TNF-α level, 728 pg/mL) and that with corn oil and 
saline (negative control) as taken as 0% (TNF-α level, 32 pg/mL). (b) NF-κB p65 in the nuclei 
of mouse liver cells was detected by Western blotting. The intensity of each band was 
analyzed, and the values relative to treatment with LPS alone are represented at the lower 
edge of the image.  
As mentioned above, eukaryotic cells reportedly contain 14 pol species belonging to four 
families (Friedberg et al., 2000; Takata et al., 2006). Among the X family of pols, pol λ has 
an unclear biochemical function, although it seems to work in a similar way to pol β 
(Garcia-Diaz et al., 2002). Pol β is involved in the short-patch base excision repair (BER) 
pathway (Matsumoto & Kim, 1995; Singhal & Wilson, 1993; Sobol et al., 1996), as well as 
playing an essential role in neural development (Sugo et al., 2000). Recently, pol λ was 
found to possess 5'-deoxyribose-5-phosphate (dRP) lyase activity, but not 
apurinic/apyrimidinic (AP) lyase activity (Garcia-Diaz et al., 2001). Pol λ is able to 
substitute for pol β during in vitro BER, suggesting that pol λ also participates in BER. 
Northern blot analysis indicated that transcripts of pol β are abundantly expressed in the 
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testis, thymus and brain in rats (Hirose et al., 1989), whereas pol λ is efficiently 
transcribed mostly in the testis (Garcia-Diaz et al., 2000). Bertocci et al. reported that mice 
in which pol λ expression is knocked down are not only viable and fertile, but also display 
a normal hyper-mutation pattern (Bertocci et al., 2002).  
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Fig. 8. The relationship between DNA repair by pol λ and inflammation 
As well as causing inflammation, TPA influences cell proliferation and has physiological 
effects on cells because it has tumor promoter activity (Nakamura et al., 1995). Therefore, 
anti-inflammatory agents are expected to suppress DNA replication/repair/recombination 
in nuclei in relation to the action of TPA. Because pol λ is a DNA repair-related pol (Garcia-
Diaz et al., 2002), our finding – that the molecular target of curcumin derivatives as 
monoacetyl-curcumin (13) is pol λ – is in good agreement with this expected mechanism of 
anti-inflammatory agents. As a result, any inhibitor of DNA repair-related pol λ might also 
be an inflammatory suppressor.  
9. Conclusion 
This review summarizes data showing that a major anti-inflammatory food compound, 
curcumin (2), selectively inhibits the activity of pol λ among 9 species of mammalian pols 
tested. Monoacetyl-curcumin (13) was the strongest inhibitor of pol λ among the 13 
chemically synthesized derivatives of curcumin (2), suggesting that monoacetyl-curcumin 
(13) is a potent candidate for a functional compound. In addition, the inhibitory effects of 
monoacetyl-curcumin (13) on inflammatory responses in comparison to those of curcumin 
(2) in vitro and in vivo were investigated. Monoacetyl-curcumin (13) suppressed NF-κB 
activation induced by LPS and TNF-α in RAW264.7 murine macrophages. Moreover, 
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monoacetyl-curcumin (13) exerted inhibitory effects on TNF-α production and NF-κB 
activation in an animal model of LPS-induced acute inflammation. These results of the 
chemical knock out of pol λ by monoacetyl-curcumin (13) suggest that the inhibition of  
pol λ, which is a DNA repair-related pol, is related to anti-inflammatory processes.  
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